About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Current Challenges of R/R MM Management and Innovation Updates
Current Challenges of R/R MM Management and Innovation Updates
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
O
Outcomes of MM Pts Progressing After BCMA-Targeted CAR T-Cell Therapy
By
Oliver Van Oekelen
70 views
January 4, 2023
0 Comments
Login to view comments.
Click here to Login
Current Challenges of R/R MM Management and Innovation Updates
07:05
ASH 2022 Conference Coverage
ASH 2022 Phase 1/2 Results From MonumenTAL-1: Talquetamab, a G Prote…
Feat.
A. Chari
25:36
MyCancerHaven
Experts Discuss the Bispecific Antibody Talquetamab in Patients With…
Feat.
R. Vij,
G. Kaur
17:42
Abdullah Khan
Treatment Approach in Patients With R/R MM Who Have Failed at Least …
41:23
Cleveland Clinic Taussig Cancer Institute
Understanding Resistance in R/R MM: Mechanisms, Current Practice, an…
Feat.
F. Anwer
20:11
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Combination Therapy Trials in Myeloma - A …
Feat.
A. Jakubowiak
03:33
ecancer
ASCO® 2023 Insights: "TRIMM-2 Study Summary - Update on Talquet…
Feat.
B. Dholaria
05:20
ecancer
ASCO® 2023 Insights: "RedirecTT-1 Study Summary - Teclistamab +…
Feat.
Y. C. Cohen
52:39
Yale Cancer Center
Myeloma in 2023: So Many Drugs, Yet So Few Cures
Feat.
A. Chari
09:10
University of Colorado Division of Hematology
2023 Denver ASH Review: Updates in Multiple Myeloma (Updates in the …
Feat.
D. Sherbenou
32:03
Indy Hematology Review
Emerging and Current Treatment of MM: What Should We Know and What S…
Feat.
K. Anderson
54:12
Dana-Farber Cancer Institute
Symptom Management in Multiple Myeloma
Feat.
S. Midha
44:49
Dana-Farber Cancer Institute
Recent Updates in Multiple Myeloma
Feat.
K. Anderson
27:10
Yale Cancer Center
Highlights in R/R Myeloma and AL Amyloidosis From ASH 2022
Feat.
S. Browning
19:18
Total Health
Updates to Management of Patients With Multiple Myeloma
Feat.
S. Kumar
41:46
Yale Cancer Center
Early Detection and Interception in Myeloma: The PROMISE Study
Feat.
I. Ghobrial
17:32
Current Challenges in Hematology
Patient Journey for a Transplant-Ineligible Patient With MM From 1L …
Feat.
R. Mina
15:32
ASH 2022 Conference Coverage
Novel Approaches to Myeloma Burden Assessment
Feat.
T. Kourelis
06:16
ASH 2022 Conference Coverage
U.S. Myeloma CAR-T Consortium Real World Experience: Factors Associa…
Feat.
H. Hashmi
14:16
ASH 2022 Conference Coverage
Assessing Disease Risk in Multiple Myeloma: High or Low?
Feat.
T. Schmidt
12:43
Oliver Van Oekelen
Outcomes of MM Pts Progressing After BCMA-Targeted CAR T-Cell Therapy